Hospitalization due to COVID-19 was also identified as having a marginal negative effect on circulating ADAM17 levels (extracellular domain, coefficient = −0.02, 95% CI −0.04–0, IVW method) (Figure 1b, Supplementary Table S5). The gene discussed is ADAM17; the disease is COVID-19.